Tokuhara Takaya, Tanigawa Nobuhiko, Matsuki Mitsuru, Nomura Eiji, Mabuchi Hideaki, Lee Sang-Woong, Tatsumi Yoshiaki, Nishimura Haruto, Yoshinaka Ryoji, Kurisu Yoshitaka, Narabayashi Isamu
Department of General and Gastroenterological Surgery, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan.
Gastric Cancer. 2008;11(4):194-200. doi: 10.1007/s10120-008-0480-9. Epub 2009 Jan 8.
We assessed the value of magnetic resonance imaging (MRI), using ultrasmall superparamagnetic iron oxide (USPIO) with new diagnostic criteria, in the evaluation of regional lymph node metastases in gastric cancer.
Thirty-one patients with gastric cancer were enrolled. 1000 lymph nodes were dissected during surgery, and of these, 519 nodes (51.9%) were identified by currently used MRI imaging analysis. We evaluated lymph nodes on USPIO-post-contrast T2*-weighted images using the following two criteria: (1) we diagnosed the nodes on T2*-weighted images according to conventional criteria, where a node having an overall low signal intensity (pattern A) was nonmetastatic, while a node having partial (pattern B) or overall (pattern C) high signal intensity was metastatic; (2) we subdivided pattern B nodes on T1-weighted images using the new criteria, in which a node for which the high-intensity area on T2*-weighted images was not defined as adipose tissue on T1-weighted images (pattern B1) was metastatic, while a node for which the high-intensity area was defined as adipose tissue (pattern B2) was nonmetastatic.
(1) The results using the conventional criteria were 96.2% sensitivity, 92.5% specificity, 76.3% positive predictive value (PPV), 99.0% negative predictive value (NPV), and 93.3% accuracy. (2) The results using the new criteria were 96.2% sensitivity, 98.3% specificity, 90.1% PPV, 99.0% NPV, and 97.1% accuracy.
The assessment of lymph node metastases from USPIO-post-contrast MRI alone using the new criteria was useful in the diagnosis of regional lymph node metastases in gastric cancer.
我们评估了使用超小型超顺磁性氧化铁(USPIO)并采用新诊断标准的磁共振成像(MRI)在评估胃癌区域淋巴结转移中的价值。
纳入31例胃癌患者。手术中解剖了1000个淋巴结,其中519个淋巴结(51.9%)通过目前使用的MRI成像分析得以识别。我们在USPIO增强后T2加权图像上使用以下两个标准评估淋巴结:(1)我们根据传统标准在T2加权图像上诊断淋巴结,其中整体信号强度低的淋巴结(模式A)为非转移性,而部分(模式B)或整体(模式C)信号强度高的淋巴结为转移性;(2)我们使用新标准在T1加权图像上对模式B淋巴结进行细分,其中T2*加权图像上高强度区域在T1加权图像上未被定义为脂肪组织的淋巴结(模式B1)为转移性,而高强度区域被定义为脂肪组织的淋巴结(模式B2)为非转移性。
(1)使用传统标准的结果为敏感性96.2%、特异性92.5%、阳性预测值(PPV)76.3%、阴性预测值(NPV)99.0%、准确性93.3%。(2)使用新标准的结果为敏感性96.2%、特异性98.3%、PPV 90.1%、NPV 99.0%、准确性97.1%。
仅使用新标准通过USPIO增强后MRI评估淋巴结转移对胃癌区域淋巴结转移的诊断是有用的。